Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment

L. K. Dzeranova, S. Y. Vorotnikova, A. S. Shutova, E. A. Pigarova, M. I. Yevloyeva

Open source

DOI
10.14341/omet13036
Published
2023-11-14
Container
Obesity and metabolism
Publisher
Endocrinology Research Centre
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14341/omet13036,
  title = {Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment},
  author = {L. K. Dzeranova and S. Y. Vorotnikova and A. S. Shutova and E. A. Pigarova and M. I. Yevloyeva},
  year = {2023},
  journal = {Obesity and metabolism},
  doi = {10.14341/omet13036},
  url = {https://doi.org/10.14341/omet13036}
}

RIS

TY  - JOUR
TI  - Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment
AU  - L. K. Dzeranova
AU  - S. Y. Vorotnikova
AU  - A. S. Shutova
AU  - E. A. Pigarova
AU  - M. I. Yevloyeva
PY  - 2023
JO  - Obesity and metabolism
DO  - 10.14341/omet13036
UR  - https://doi.org/10.14341/omet13036
ER  - 

APA

Dzeranova, L. K., Vorotnikova, S. Y., Shutova, A. S., Pigarova, E. A., & Yevloyeva, M. I. (2023). Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment. Obesity and metabolism. https://doi.org/10.14341/omet13036

Source records